Plc Glaxosmithkline - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 22,315 shares made by Kevin Lee , a net sale of 6,739 shares made by Alistair Milnes , and a net sale of 6,739 shares made by Michael Skynner .

In summary, during the past 3 months, insiders sold 7,222 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 7,222 shares. During the past 18 months, 53,826 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,826 shares.

Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 25,787 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 1,499,124 shares made by Eli Samaha .

In summary, during the past 3 months, insiders sold 1,254 shares of Theravance Biopharma Inc (TBPH) in total and bought 1,499,124 shares, with a net purchase of 1,497,870 shares. During the past 18 months, 151,016 shares of Theravance Biopharma Inc (TBPH) were sold and 1,499,124 shares were bought by its insiders, resulting in a net purchase of 1,348,108 shares.

Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Progyny Inc (PGNY). Other recent insider transactions involving Progyny Inc (PGNY) include a net sale of 1,561,000 shares made by David J Schlanger , a net sale of 804,259 shares made by Peter Anevski , and a net sale of 91,679 shares made by Mark S. Livingston .

In summary, during the past 3 months, insiders sold 115,685 shares of Progyny Inc (PGNY) in total and bought 0 shares, with a net sale of 115,685 shares. During the past 18 months, 5,440,376 shares of Progyny Inc (PGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,440,376 shares.

Progyny Inc (PGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net purchase of 4,609,704 shares made by Ra Capital Healthcare Fund Lp , a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 5,120 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 43,360 shares, with a net purchase of 38,240 shares. During the past 18 months, 12,096 shares of Fulcrum Therapeutics Inc (FULC) were sold and 4,653,064 shares were bought by its insiders, resulting in a net purchase of 4,640,968 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Morphic Holding Inc (MORF). Other recent insider transactions involving Morphic Holding Inc (MORF) include a net sale of 58,357 shares made by Praveen P. Tipirneni , a net sale of 56,337 shares made by Farrell Robert E Jr , and a net sale of 127,711 shares made by Marc Schegerin .

In summary, during the past 3 months, insiders sold 0 shares of Morphic Holding Inc (MORF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 317,833 shares of Morphic Holding Inc (MORF) were sold and 1,054,776 shares were bought by its insiders, resulting in a net purchase of 736,943 shares.

Morphic Holding Inc (MORF)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 14,311 shares made by Scott Moomaw , a net sale of 7,350 shares made by Jason Adair , and a net sale of 25,591 shares made by Rajeev Saggar .

In summary, during the past 3 months, insiders sold 88,202 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 88,202 shares. During the past 18 months, 113,842 shares of Liquidia Corp (LQDA) were sold and 1,536,313 shares were bought by its insiders, resulting in a net purchase of 1,422,471 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 91,515 shares made by Sath Shukla , a net sale of 85,121 shares made by Ankit Mahadevia , and a net sale of 36,219 shares made by Timothy Keutzer .

In summary, during the past 3 months, insiders sold 0 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 316,580 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,580 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Aileron Therapeutics Inc (ALRN). Other recent insider transactions involving Aileron Therapeutics Inc (ALRN) include a net purchase of 5,301 shares made by James Brian Windsor , and a net sale of 31,151 shares made by .

In summary, during the past 3 months, insiders sold 31,151 shares of Aileron Therapeutics Inc (ALRN) in total and bought 0 shares, with a net sale of 31,151 shares. During the past 18 months, 31,151 shares of Aileron Therapeutics Inc (ALRN) were sold and 5,301 shares were bought by its insiders, resulting in a net sale of 25,850 shares.

Aileron Therapeutics Inc (ALRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in HTG Molecular Diagnostics Inc (HTGMQ). Other recent insider transactions involving HTG Molecular Diagnostics Inc (HTGMQ) include a net sale of 888 shares made by Stephen Barat ,

In summary, during the past 3 months, insiders sold 0 shares of HTG Molecular Diagnostics Inc (HTGMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 888 shares of HTG Molecular Diagnostics Inc (HTGMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 888 shares.

HTG Molecular Diagnostics Inc (HTGMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 325,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .

In summary, during the past 3 months, insiders sold 89,721 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 89,721 shares. During the past 18 months, 334,721 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 334,721 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Innoviva Inc (INVA). Other recent insider transactions involving Innoviva Inc (INVA) include a net purchase of 723,000 shares made by Alexander J Denner , a net sale of 10,994 shares made by Marianne Zhen , and a net purchase of 3,000 shares made by Pavel Raifeld .

In summary, during the past 3 months, insiders sold 0 shares of Innoviva Inc (INVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,994 shares of Innoviva Inc (INVA) were sold and 726,000 shares were bought by its insiders, resulting in a net purchase of 715,006 shares.

Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 634,200 shares made by John F Crowley , a net sale of 260,446 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .

In summary, during the past 3 months, insiders sold 115,222 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 115,222 shares. During the past 18 months, 1,232,982 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,232,982 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Concert Pharmaceuticals Inc (CNCE). Other recent insider transactions involving Concert Pharmaceuticals Inc (CNCE) include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 12,999 shares made by James V Cassella , and a net sale of 11,386 shares made by Jeffrey A Munsie .

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,104 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,104 shares.

Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of OncoMed Pharmaceuticals Inc (OMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoMed Pharmaceuticals Inc (OMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

OncoMed Pharmaceuticals Inc (OMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Response Genetics Inc (RGDXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Response Genetics Inc (RGDXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Response Genetics Inc (RGDXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Quest Diagnostics Inc (DGX). Other recent insider transactions involving Quest Diagnostics Inc (DGX) include a net sale of 56,044 shares made by Catherine T. Doherty , a net sale of 12,441 shares made by Michael E Prevoznik , and a net sale of 2,500 shares made by Vicky B Gregg .

In summary, during the past 3 months, insiders sold 18,097 shares of Quest Diagnostics Inc (DGX) in total and bought 0 shares, with a net sale of 18,097 shares. During the past 18 months, 74,770 shares of Quest Diagnostics Inc (DGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 74,770 shares.

Quest Diagnostics Inc (DGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anacor Pharmaceuticals Inc (ANAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anacor Pharmaceuticals Inc (ANAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anacor Pharmaceuticals Inc (ANAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in CVRx Inc (CVRX). Other recent insider transactions involving CVRx Inc (CVRX) include a net sale of 8,895 shares made by Paul Verrastro , and a net sale of 3,725 shares made by Johnson & Johnson .

In summary, during the past 3 months, insiders sold 6,270 shares of CVRx Inc (CVRX) in total and bought 0 shares, with a net sale of 6,270 shares. During the past 18 months, 12,620 shares of CVRx Inc (CVRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,620 shares.

CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net sale of 58,020 shares made by Richard Klausner ,

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,020 shares of Lyell Immunopharma Inc (LYEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 58,020 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made no insider transaction in 23andMe Holding Co (ME). Other recent insider transactions involving 23andMe Holding Co (ME) include a net sale of 926,942 shares made by Kathy L Hibbs , and a net sale of 2,538 shares made by William G Richards .

In summary, during the past 3 months, insiders sold 269,839 shares of 23andMe Holding Co (ME) in total and bought 0 shares, with a net sale of 269,839 shares. During the past 18 months, 929,480 shares of 23andMe Holding Co (ME) were sold and 0 shares were bought by its insiders, resulting in a net sale of 929,480 shares.

23andMe Holding Co (ME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Plc Glaxosmithkline made 1 insider transaction in WAVE Life Sciences Ltd (WVE) with a net purchase of 3,300,000. Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 62,421 shares made by Kyle Moran , a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 29,400 shares made by Paul Bolno .

In summary, during the past 3 months, insiders sold 15,630 shares of WAVE Life Sciences Ltd (WVE) in total and bought 0 shares, with a net sale of 15,630 shares. During the past 18 months, 112,328 shares of WAVE Life Sciences Ltd (WVE) were sold and 5,300,000 shares were bought by its insiders, resulting in a net purchase of 5,187,672 shares.

WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.